Gabapentin to Control Seizures in Children Undergoing Cancer Treatment

Abstract

Hepatic clearance of chemotherapy drugs is increased by many antiepilepsy drugs. At our institution, new-onset seizures in children on chemotherapy are treated with gabapentin, a nonhepatic enzyme inducer. The charts of all children given gabapentin for seizures were reviewed. At a median follow-up of 34 months, seizures were controlled in 74% of 50 children given gabapentin monotherapy as initial treatment: 91% of the leukemia group, 57% of the brain tumor group, and 75% of the other tumor group. Seizures were controlled in 49% of 59 children in whom gabapentin was added to other antiepilepsy drugs: 43% of the leukemia group, 53% of the brain tumor group, and 50% of the other tumor group. More than one seizure at presentation, focal neurologic deficits, high-dose methotrexate, brain irradiation, and T₂-weighted signal abnormality around the brain tumor cavity predicted uncontrolled seizures. Only 8 children (7%) reported adverse effects, and the drug was discontinued in two. Gabapentin effectively controls seizures in children receiving chemotherapy and is well tolerated. (J Child Neurol 2004;19:97—101).

Get full access to this article

View all access options for this article.

References

Winick NJ , Bowman WP , Kamen BA , et al: Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 1992;84:252—256.

Ochs JJ , Bowman WP , Pui CH , et al: Seizures in childhood lymphoblastic leukaemia patients. Lancet 1984;2:1422—1424.

Mahoney DHJr , Shuster JJ , Nitschke R. , et al: Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study . J Clin Oncol 2000;18:1285—1294.

Pace A. , Bove L. , Innocenti P. , et al. Epilepsy and gliomas: Incidence and treatment in 119 patients . J Exp Clin Cancer Res 1998; 17:479—482.

Villikka K. , Kivisto KT , Maenpaa H. , et al: Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther 1999;66:589—593.

Zamboni WC , Gajjar AJ , Heideman RL , et al: Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma. Clin Cancer Res 1998;4:783—789.

Williams ML , Wainer IW , Embree L. , et al: Enantioselective induction of cyclophosphamide metabolism by phenytoin. Chirality 1999;11:569—574.

Grossman SA , Hochberg F. , Fisher J. , et al: Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy. Cancer Chemother Pharmacol 1998;42:118—126.

Relling MV , Pui CH , Sandlund JT , et al: Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000;356:285—290.

10.

Khafaga YM , Jamshed A. , Allam AA , et al: Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy. Acta Oncol 1999;38:111—116.

11.

Beydoun A. : Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 1999;40(Suppl 6):S13—S16.

12.

Brodie MJ , Chadwick DW , Anhut H. , et al: Gabapentin versus lamotrigine monotherapy: A double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002 ;43:993—1000.

13.

Chadwick DW , Anhut H. , Greiner MJ , et al: A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77 . Neurology 1998;51:1282—1288.

14.

Berry DJ , Beran RG , Plunkeft MJ , et al: The absorption of gabapentin following high dose escalation . Seizure 2003;12:28—36.

15.

Nelder JA , Wedderburn Rwm : Generalized linear models. J R Stat Soc 1972 ;A135:370—384.

16.

MacDonald B. : The prognosis of epilepsy. Seizure 2001;10:347—358.

17.

Kwan P. , Brodie MJ : Early identification of refractory epilepsy. N Engl J Med 2000;342:314—319.

18.

Hauser E. , Freilinger M. , Seidl R. , Groh C. : Prognosis of childhood epilepsy in newly referred patients. J Child Neurol 1996;11:201—204.

19.

Moots PL , Maciunas RJ , Eisert DR , et al: The course of seizure disorders in patients with malignant gliomas . Arch Neurol 1995;52:717—724.

20.

Glantz MJ , Cole BF , Forsyth PA , et al: Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886—1893.